Key Rubella Treatment Market Players:
- Merck & Co., Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GlaxoSmithKline plc (GSK)
- Sanofi Pasteur
- Pfizer Inc.
- Novartis AG
- Takeda Pharmaceutical Company
- Bavarian Nordic A/S
- CSL Limited
- Serum Institute of India Pvt. Ltd.
- Biological E. Limited
- Johnson & Johnson
- AstraZeneca PLC
- Mitsubishi Tanabe Pharma
- Green Cross Corp
- KM Biologics
- Panacea Biotec
- Bio Farma
- Zuellig Pharma
- Probiomed
- Sinovac Biotech Ltd.
The rubella treatment market is very competitive, with strong market players from global pharmaceutical giants to regional players. Leading manufacturers such as Pfizer, GSK, Sanofi, and Merck lead the vaccine manufacturing. Meanwhile, companies like CSL, Grifols, and Kedrion are specializing in IVIG therapies for congenital rubella syndrome. Further manufacturers such as Bharat Biotech, Serum Institute of India, and LG Chem focus on affordability and access in low- and middle-income regions. As governments expand maternal health programs, competitive advantage is dependent on cost, biologic R&D, and responsive supply chain infrastructure.
Below is the list of some prominent players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of the rubella treatment market was over USD 258.2 million.
The market size for the rubella treatment market is projected to reach USD 426.9 million by the end of 2035, expanding at a CAGR of 5.5% during the forecast period, i.e., between 2026 and 2035.
The major players in the market are Merck & Co., Inc., GlaxoSmithKline plc (GSK), Sanofi Pasteur, Pfizer Inc., Novartis AG, Takeda Pharmaceutical Company, and others.
In terms of the healthcare channel, the hospitals segment is anticipated to garner the largest market share of 46.5% by 2035 and display lucrative growth opportunities during 2026-2035.
The market in the Asia Pacific is projected to hold the largest market share of 38.9% by the end of 2035 and provide more business opportunities in the future.
